Description
| COMPOSITION: | Each film coated modified released tablet contains Trimetazidine Dihydrochloride 20 mg |
| FORMULATION: | TABLETS |
| STATUS: | PRESCRIPTION ONLY DRUG |
| DESCRIPTION: | Vasotrim-35 MR tablet contains Trimetazidine which is a piperazine derivative indicated for the symptomatic treatment of stable angina pectoris in patients inadequately controlled or intolerant to first line therapies. |
| SIDE EFFECTS: | Nausea, vomiting, fatigue, dizziness, and myalgia. The drug can induce or increase parkinsonian symptoms: extrapyramidal rigidity, bradykinesia, and tremor. |
| DOSAGE/DIRECTIONS FOR USE: | As Prescribed by Physician Trimetazidine |
Reviews
There are no reviews yet.